Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NIVA BUPA HEALTH INSURANCE COMPANY LTD.

NSE : NIVABUPABSE : 544286ISIN CODE : INE995S01015Industry : InsuranceHouse : Max

BSE82.047.59 (+10.19 %)

PREV CLOSE ( ) 74.45

OPEN PRICE ( ) 74.66

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2198641

TODAY'S LOW / HIGH ( )74.66 84.80

52 WK LOW / HIGH ( )69.2 80.94

NSE81.937.54 (+10.14 %)

PREV CLOSE( ) 74.39

OPEN PRICE ( ) 75.16

BID PRICE (QTY) 81.93 (15304)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26815355

TODAY'S LOW / HIGH( ) 74.75 84.80

52 WK LOW / HIGH ( )69.21 81

Select year

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Operational & Financial Ratios

Earnings Per Share (Rs)

0.48

0.08

-1.40

-0.37

-0.55

CEPS(Rs)

0.48

0.08

-1.40

-0.37

-0.55

DPS(Rs)

0.00

Book NAV/Share(Rs)

12.06

5.50

3.60

4.27

3.07

Tax Rate(%)

0.00

Margin Ratios

Core EBITDA Margin(%)

-5.12

-5.54

-17.91

-9.36

-8.48

EBIT Margin(%)

2.15

0.47

-11.21

-4.32

-7.32

Pre Tax Margin(%)

2.15

0.47

-11.21

-4.32

-7.32

PAT Margin (%)

2.15

0.47

-11.21

-4.32

-7.32

Cash Profit Margin (%)

2.15

0.47

-11.21

-4.32

-7.32

Performance Ratios

ROA(%)

4.85

1.37

-29.50

-10.78

-20.23

ROE(%)

5.68

1.87

-36.26

-10.78

-20.24

ROCE(%)

4.84

1.36

-29.46

-10.78

-20.24

Asset Turnover(x)

2.26

2.90

2.63

2.49

2.76

Sales/Fixed Asset(x)

15.81

12.81

9.89

7.42

6.27

Working Capital/Sales(x)

Efficiency Ratios

Fixed Capital/Sales(x)

0.06

0.08

0.10

0.13

0.16

Receivable days

0.00

Inventory Days

0.00

Payable days

Valuation Parameters

PER(x)

0.00

PCE(x)

0.00

Price/Book(x)

0.00

Yield(%)

EV/Net Sales(x)

0.41

0.53

0.77

1.15

1.32

EV/Core EBITDA(x)

8.28

4.01

29.94

10.56

9.45

EV/EBIT(x)

19.02

112.34

-6.87

-26.52

-17.99

EV/CE(x)

M Cap / Sales

0.00

Growth Ratio

Net Sales Growth(%)

43.13

51.94

52.28

36.83

27.54

Core EBITDA Growth(%)

-46.42

678.44

-63.92

6.66

36.67

EBIT Growth(%)

552.68

106.38

-295.11

19.19

-27.21

PAT Growth(%)

552.68

106.38

-295.11

19.19

-27.21

EPS Growth(%)

480.15

105.95

-278.60

32.59

-10.83

Financial Stability Ratios

Total Debt/Equity(x)

0.00

Current Ratio(x)

0.17

0.16

0.14

0.17

0.14

Quick Ratio(x)

0.17

0.16

0.14

0.17

0.14

Interest Cover(x)

Total Debt/Mcap(x)